|
|
Volumn 17, Issue 10, 1999, Pages 963-968
|
|
Tumor angiogenesis - New drugs on the block
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID;
4 [4,4 (CHLOROPHENYL)PHENYL] 4 OXO (PHENYLTHIOMETHYL)BUTANOIC ACID;
4 DEDIMETHYLAMINOSANCYCLINE;
5 AMINO 1 [3,5 DICHLORO 4 (4 CHLOROBENZOYL)BENZYL] 1H 1,2,3 TRIAZOLE 4 CARBOXAMIDE;
AE 941;
ALPHA INTERFERON;
ANGIOGENESIS INHIBITOR;
ANGIOSTATIN;
ANGIOZYME;
ANTITHROMBIN;
CGS 27023A;
CILENGITIDE;
COMBRETASTATIN;
ENDOSTATIN;
FUMAGILLOL CHLOROACETYLCARBAMATE;
IM 862;
INTERLEUKIN 12;
LEFLUNOMIDE;
MARIMASTAT;
MONOCLONAL ANTIBODY LM 609;
PENTOSAN POLYSULFATE;
PRINOMASTAT;
REBIMASTAT;
SEMAXANIB;
SQUALAMINE;
TROPONIN 1;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VATALANIB;
ZD 0101;
ZK 225846;
ANGIOGENESIS;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
DRUG MECHANISM;
ENDOTHELIUM CELL;
HUMAN;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PLASMA HALF LIFE;
PRIORITY JOURNAL;
REVIEW;
ANGIOGENESIS INHIBITORS;
CELL DIVISION;
CLINICAL TRIALS;
ENDOTHELIUM, VASCULAR;
HUMANS;
HYDROLYSIS;
INTEGRINS;
NEOPLASMS;
SIGNAL TRANSDUCTION;
|
|
EID: 0032829104
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/13654 Document Type: Review |
|
Times cited : (153)
|
|
References (6)
|
